In March 2011, the FDA placed the trial on clinical hold due to GMP compliance issues at the contract manufacturer not safety concerns with RGN-352 itself
doi: 10.1159/000381768 16 KahalyGJRiedlMKnigJDianaTSchomburgL
And, when we look at studies to try to determine what does cause them, many patients describe a history of trauma to the area involved
Monitoring is necessary with treatment, and cognition should return to normal (Budson & Solomon, 2015)
Tirzepatide has documented improvements in blood pressure, lipids, and other cardiometabolic parameters across its phase 3 program, consistent with its degree of weight loss, and cardiovascular outcome data continue to accumulate
What evidence supports effects on libido or sexual function